frankmulticampeon.bsky.social
@frankmulticampeon.bsky.social
Proper Definition of Postprostatectomy Prostate-Specific Antigen Persistence url:https://jamanetwork.com/journals/jamaoncology/fullarticle/2836494?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=071725
July 17, 2025 at 9:58 PM
Reposted
Early-Onset Gastrointestinal Cancers: A Review url:https://jamanetwork.com/journals/jama/fullarticle/2836671?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=071725
Cánceres gastrointestinales de aparición temprana
Una reseña
July 17, 2025 at 9:55 PM
Early-Onset Gastrointestinal Cancers: A Review url:https://jamanetwork.com/journals/jama/fullarticle/2836671?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=071725
Cánceres gastrointestinales de aparición temprana
Una reseña
July 17, 2025 at 9:55 PM
Reposted
Este corte anatómico muestra cómo la obesidad afecta internamente al cuerpo: órganos comprimidos, articulaciones desgastadas y un corazón sobrecargado. Más allá de lo estético, revela el impacto real en la salud y la importancia de prevenir con hábitos saludables.
July 15, 2025 at 10:00 PM
Reposted
Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy url:https://jamanetwork.com/journals/jamaoncology/fullarticle/2835449?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=071125
July 11, 2025 at 8:04 PM
Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy url:https://jamanetwork.com/journals/jamaoncology/fullarticle/2835449?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=071125
July 11, 2025 at 8:04 PM
Supervivencia global y seguridad a largo plazo actualizadas con ripretinib frente a sunitinib en pacientes con tumores del estroma gastrointestinal: análisis final de supervivencia global de INTRIGUE | Revista de Oncología Clínica ascopubs.org/doi/full/10....
ASCO Publications
ascopubs.org
July 10, 2025 at 12:06 AM
Supervivencia global y seguridad a largo plazo actualizadas con ripretinib frente a sunitinib en pacientes con tumores del estroma gastrointestinal: análisis final de supervivencia global de INTRIGUE | Revista de Oncología Clínica ascopubs.org/doi/full/10....
Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE
In the INTRIGUE phase III trial (ClinicalTrials.gov identifier: NCT03673501), adult patients with advanced gastrointestinal stromal tumor previously treated with imatinib were randomly assigned 1:1 to...
ascopubs.org
July 10, 2025 at 12:05 AM
Evaluación del estado funcional de los genes del antígeno leucocitario humano de clase I en tejidos cancerosos en el contexto de la inmunoterapia con vacunas peptídicas personalizadas de neoantígenos | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10....
Assessment of Functional Status of Human Leukocyte Antigen Class I Genes in Cancer Tissues in the Context of Personalized Neoantigen Peptide Vaccine Immunotherapy | JCO Clinical Cancer Informatics
PURPOSEAccurate human leukocyte antigen (HLA) typing is an essential step for designing peptide vaccines used in the personalized neoantigen peptide vaccine immunotherapy (PNPVT) in patients with canc...
ascopubs.org
July 10, 2025 at 12:04 AM
Reposted
PRODIGE 29-UCGI 26 (NEOPAN): Ensayo aleatorizado de fase III que compara la quimioterapia con FOLFIRINOX o gemcitabina en el carcinoma de páncreas localmente avanzado | Revista de Oncología Clínica ascopubs.org/doi/abs/10.1...
PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma
PURPOSEMore than 30% of patients with pancreatic cancer are unresectable because of the local extension with a median overall survival (OS) of <1 year. Combination of fluorouracil (FU), oxaliplatin...
ascopubs.org
July 9, 2025 at 2:23 PM
PRODIGE 29-UCGI 26 (NEOPAN): Ensayo aleatorizado de fase III que compara la quimioterapia con FOLFIRINOX o gemcitabina en el carcinoma de páncreas localmente avanzado | Revista de Oncología Clínica ascopubs.org/doi/abs/10.1...
PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma
PURPOSEMore than 30% of patients with pancreatic cancer are unresectable because of the local extension with a median overall survival (OS) of <1 year. Combination of fluorouracil (FU), oxaliplatin...
ascopubs.org
July 9, 2025 at 2:23 PM
Reposted
Robotic Surgery for Rectal Cancer url:https://jamanetwork.com/journals/jama/fullarticle/2834895?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=070825
July 8, 2025 at 9:31 PM
Robotic Surgery for Rectal Cancer url:https://jamanetwork.com/journals/jama/fullarticle/2834895?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=070825
July 8, 2025 at 9:31 PM
Reposted
She turns toward the light not to escape the dark, but to remind it she’s more radiant. There’s grace in her stillness, a quiet defiance in her softness. Every curve, every glance, whispers of beauty that doesn’t need to shout. She is not fragile—she is...

artofonesandzeros.com/2025/07/07/v...
July 7, 2025 at 10:23 AM